In the lead up to the Melbourne Cup, it’s likely you’ll be hearing the name Incentivise, a horse who has stormed to Cup favouritism after his dominant win in the Caulfield Cup. But well before his Group 1 winning accolades were achieved, the boom horse’s humble beginnings trace back to Southern Queensland, a horse racing
Read More
Employee wellness has been at the forefront of employer’s minds since the pandemic pulled us out of the office and left us as tracksuit clad, makeup free recluses. At least in my case anyway. Digital employee wellness company Limeade (ASX: LME) has seen organisation wide growth indicated by their increase in headcount and operating cash
Read More
Major US indices managed to reverse their early selling to mostly finish stronger overnight. Tech stocks powered the rebound and the tech-heavy NASDAQ index was the strongest of the major indices overnight. There were not a whole lot of major reporting stocks overnight in the US, but things ramp back up tonight with J&J, Netflix,
Read More
Over the next 20 years, more than $3.5 trillion of wealth is set to be transferred from the Baby Boomer generation to their beneficiaries. Foreseeing the administration of this wealth management as a hugely lucrative market, fintech company HUB24 (ASX: HUB) is set to acquire market leader Class Limited (ASX: CL1) at an impressive premium
Read More
Shareholders who took a punt on Argenica Therapeutics (ASX: AGN) when they made their market debut earlier this year will be pleased to read the Company’s roadmap to Phase 1 clinical trials. The recently-listed Company has been subjected to the trials and tribulations of being listed, with a sharp sell-down post-IPO leaving their share price
Read More